Budesonide in pharma franchise in Rajasthan

Budesonide in PCD pharma franchise in Ranchi

Budesonide in top pharma company in Rajkot

Budesonide in pcd pharma supplier in Ranchi

Budesonide in phama franchise company in India
Budesonide in phama distributor in Tiruchirappalli

Home/Products /budesonide-200mcg-inhaler

Buditerm 200 Inhaler

Composition : Budesonide (200mcg) Inhaler

Dosage Form : Inhaler

Packaging Type : Carton and Leaflet

Packaging : 200 Metered Dose

Price : ₹434.5/-

Buditerm 200 Inhaler, containing Budesonide (200mcg), is a corticosteroid used to manage and prevent symptoms of asthma and chronic obstructive pulmonary disease (COPD). Budesonide works by reducing inflammation in the airways, thereby helping to ease breathing and preventing asthma attacks. It is a maintenance therapy that must be used regularly as prescribed to achieve optimal results. Budesonide minimizes airway swelling and mucus production, allowing for improved airflow and respiratory function.

This inhaler is effective for individuals with persistent asthma who require long-term control of symptoms. It is not designed for the immediate relief of acute bronchospasm or asthma attacks; a fast-acting bronchodilator should be used in such cases. Buditerm 200 Inhaler is suitable for adults and children over the age of 6, with the dosage tailored to the severity of the condition.

Buditerm 200 Inhaler belongs to the Asthma and Pulmonary Respiratory therapy category. Its consistent use can significantly improve the quality of life for individuals with respiratory disorders by minimizing symptoms and preventing exacerbations.

Read More

About the Product

Buditerm 200 Inhaler, containing Budesonide (200mcg), is a corticosteroid used to manage and prevent symptoms of asthma and chronic obstructive pulmonary disease (COPD). Budesonide works by reducing inflammation in the airways, thereby helping to ease breathing and preventing asthma attacks. It is a maintenance therapy that must be used regularly as prescribed to achieve optimal results. Budesonide minimizes airway swelling and mucus production, allowing for improved airflow and respiratory function.

This inhaler is effective for individuals with persistent asthma who require long-term control of symptoms. It is not designed for the immediate relief of acute bronchospasm or asthma attacks; a fast-acting bronchodilator should be used in such cases. Buditerm 200 Inhaler is suitable for adults and children over the age of 6, with the dosage tailored to the severity of the condition.

Buditerm 200 Inhaler belongs to the Asthma and Pulmonary Respiratory therapy category. Its consistent use can significantly improve the quality of life for individuals with respiratory disorders by minimizing symptoms and preventing exacerbations.

Common side effects include throat irritation, cough, and oral thrush. Serious but rare side effects include adrenal suppression and vision changes.

Buditerm 200 Inhaler is indicated for the management and prevention of asthma symptoms and the treatment of chronic obstructive pulmonary disease (COPD).

Use regularly as prescribed, even when symptoms are not present. Rinse your mouth after use to prevent oral thrush. Not for immediate relief of asthma attacks.

Store at room temperature (20°C to 25°C) in a dry place, away from direct sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation